Background
Methods
Design
Participants
Microwave therapy
Data collection
Data analysis
Results
Participants
N | 45 | |
Gender, n (%) | Female | 25 (56%) |
Male | 20 (44%) | |
Age, mean (SD), years | 46.6 (19.2) | |
Medical history | Dyslipidaemia | 2 (4%) |
Diabetes Mellitus | 1 (2%) | |
Sarcoidosis | 1 (2%) | |
Obesity | 1 (2%) | |
Crohn’s disease | 1 (2%) | |
Asthma medication (steroid) | 3 (7%) | |
Number of plantar warts per participant | Single | 12 (27%) |
Multiple | 33 (73%) | |
Mean (SD) | 3.3 (2.6) | |
Median (range) | 3.0 (1–10) | |
Previous treatment, n (%) | Yes | 33 (73%) |
No | 12 (27%) | |
Previous treatmentsa, n (%) | Cryotherapy | 14 (31%) |
Salicylic acid | 19 (42%) | |
AgNO3 | 10 (22%) | |
Needling | 5 (11%) | |
Surgery | 2 (4%) | |
Natural remedies | 3 (6%) | |
Pharmacy | 16 (36%) | |
General practitioner | 8 (18%) | |
Podiatrist | 11 (24%) |
Plantar warts
All (n = 150) | Resolved (n = 125) | Not resolved (n = 25) | P-valued | |||
---|---|---|---|---|---|---|
Location, n (%) | Rearfoot (n = 38) | Heel | 38 (25%) | 32 (26%) | 6 (24%) | 0.587 |
Forefoot (n = 103) | First metatarsal head | 17 (11%) | 14 (11%) | 3 (12%) | ||
Fifth metatarsal head | 17 (11%) | 14 (11%) | 3 (12%) | |||
Hallux | 16 (11%) | 14 (11%) | 2 (8%) | |||
Second metatarsal head | 15 (10%) | 12 (10%) | 3 (12%) | |||
Fourth metatarsal head | 14 (9%) | 10 (10%) | 4 (4%) | |||
Third metatarsal head | 10 (7%) | 7 (7%) | 3 (12%) | |||
Second toe | 9 (6%) | 9 (7%) | 0 (0%) | |||
Fifth toe | 3 (2%) | 3 (2%) | 0 (0%) | |||
Third toe | 2 (1%) | 1 (1%) | 1 (4%) | |||
Midfoot (n = 9) | Lateral arch | 5 (3%) | 5 (4%) | 0 (0%) | ||
Medial arch | 4 (3%) | 4 (3%) | 0 (0%) | |||
Foot side, n (%) | Left | 68 (45%) | 57 (46%) | 11 (44%) | 0.857 | |
Right | 82 (55%) | 67 (54%) | 14 (56%) | |||
Duration, months, mean (SD)a | 35.2 (41.0) | 33.8 (42.2) | 42.3 (35.8) | 0.413 | ||
Lesion diameter, mm, mean (SD) | 6.3 (7.9) | 6.67 (8.6) | 4.32 (1.9) | 0.205 | ||
Total treatment sessions, mean (SD), range | 2.8 (1.0), 1–6 | 2.8 (1.0), 1–6 | 3.2 (1.0), 1–5 | 0.043 | ||
Average applications per treatment session, mean (SD) | 2.0 (0.8) | 1.9 (0.8) | 2.3 (0.7) | 0.023 | ||
Average watts setting per application, mean (SD) | 7.5 (2.2) | 7.4 (2.1) | 7.9 (2.3) | 0.335 | ||
Average frequency setting per application, mean (SD) | 6.2 (2.8) | 6.4 (3.0) | 5.6 (1.7) | 0.213 | ||
Average painb,c on arrival per treatment session, mean (SD) | 0.71 (1.2) | 0.8 (1.2) | 0.0 (0.0) | < 0.001 | ||
Average painb,c during treatment per treatment session, mean (SD) | 7.8 (1.1) | 7.7 (1.1) | 8.4 (0.9) | 0.009 | ||
Average painb,c on departure per treatment session, mean (SD) | 1.1 (1.5) | 1.2 (1.5) | 0.7 (1.3) | 0.288 | ||
Average joules per treatment session, mean (SD) | 155.9 (68.3) | 150.6 (54.3) | 182.3 (82.4) | 0.034 |